Andrew Barnhill serves as Head of Policy and Government Affairs. He leads the company’s engagements with governments as well as global health policy partnerships. He is responsible for assessing political risks (under the leadership of the General Counsel) and providing policy analysis to business units while also representing the company in government policy engagements. Most recently, Andrew was named to The Hill’s Top Lobbyists in 2022, 2023, and 2024 and was named one of Washington’s 500 Most Influential People by Washingtonian magazine in 2024 and 2025. Earlier in his career, Andrew built the public affairs function at BioDelivery Sciences International. For many years, Andrew served as Director of Federal Policy for GlaxoSmithKline. Andrew is also Associate Professor of Practice at New York University’s Wagner School of Public Service where he teaches health policy and policy ethics. Andrew began his career on Capitol Hill before working at a national lobbying firm. He is a member of the Economic Club of Washington and on the board of directors of the North Carolina Life Sciences Association.
Barnhill provides political analysis to the full range of businesses across the enterprise--from R&D to Real World Evidence to Commercial strategy. His political analysis is deeply integrated into enterprise-wide decision-making, helping business units anticipate risks and seize strategic opportunities. At the same time, he plays a key internal role, translating policy developments into actionable insights for cross-functional teams. This dual capacity—as an external advocate and internal communicator—positions Barnhill as a linchpin between public policy and corporate strategy, strengthening the broader life sciences ecosystem.